Publication: Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients
11
item.page.dc.date.issued
2002-07-04
item.page.dc.type
item.page.dc.identifier.issn
03618609
item.page.dc.identifier.doi
item.page.dc.identifier.other
2-s2.0-0036089573
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
American Journal of Hematology. Vol.70, No.3 (2002), 260-262
punsarn.item.page.citation
Vip Viprakasit, Suthida Kankirawatana, Pravit Akarasereenont, Kritvikrom Durongpisitkul, Sirikul Chotewuttakorn, Voravarn S. Tanphaichitr Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients. American Journal of Hematology. Vol.70, No.3 (2002), 260-262. doi:10.1002/ajh.10129 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/20462
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
We studied levels of plasma endothelin-1 (ET-1) in 25 β-thalassemia/Hb E patients before and after blood transfusion. Baseline ET-1 levels in these patients were significantly higher than in normal controls (10.17 ± 2.1 pg/mL vs. 8.9 ± 2.0 pg/mL, P < 0.05). After blood transfusion, levels of plasma ET-1 tend to slightly increase during the first 24 hr but significantly decline at the 7thday to levels (8.01 ± 1.7 pg/mL) which do not differ from those of controls. This study highlights a different alteration of plasma ET-1 in patients with β-thalassemia compared to that of patients with sickle-cell anemia. © 2002 Wiley-Liss, Inc.
